Zenkuda demonstrated superiority over sham in patients with diabetic retinopathy in the phase 3 GLOW2 study, according to a ...
A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease ...
In eye clinics and clinical trials, doctors increasingly rely on patients' own reports of how eye disease and treatment ...
Vision impairment remains one of the most pervasive and yet preventable global health challenges. Despite remarkable progress in diagnostic and therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results